16 postdoc-in-system-identification PhD positions at Heidelberg University in Germany
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
candidates with a background in cell cycle regulation/mitosis and cell biology. The duration of mitosis is tightly regulated by multiple factors, including the spindle assembly checkpoint (SAC
-
data integration, cancer systems biology, and single-cell analysis, with strong links to clinical and translational oncology. Our work is based in the dynamic research environment of Heidelberg
-
project “Single cell multi-omics to unravel niche plasticity in AML therapy resistance“ we are looking for a PhD student. The project is part of the SFB/CRC 1709 “Cellular Plasticity in Myeloid Malignancies
-
“Mitochondrial RNA modification- driven metabolic plasticity in leukemic stem cells and drug resistance“ we are looking for a PhD student. The project is is part of the SFB/CRC 1709 “Cellular Plasticity in Myeloid
-
xenograft (PDX) models. To this end, the candidate will have direct access to cutting-edge mass spectrometry and advanced bioinformatics infrastructure. The project is part of the collaborative research
-
“Multi-modal proteomics to understand and overcome niche-related adaptive drug-resistance mechanisms in FLT3-mutated AML“ we are looking for a PhD student. The project is is part of the SFB/CRC 1709
-
“Functional and molecular characterization of AI-based morphological predictors of therapy response in Acute Myeloid Leukemia“ we are looking for a PhD student. The project is is part of the SFB/CRC 1709
-
Heidelberg University is a comprehensive university with a strong focus on research and international standards. With around 31,300 students and 8,400 employees, including numerous top researchers
-
The research group of Prof. Dr. Michael Mastalerz at the Institute of Organic Chemistry, Heidelberg University is seeking the following temporary position from October 15th 2025 or later: PhD
-
Stellenanzeige teilen wanted for the next possible date at the Department of Pediatric Oncology, Hematology and Immunology . Osteosarcoma (OS) is an aggressive bone cancer mainly affecting children and young